Ichthyosis vulgaris is a common inherited skin disorder characterized by dry, scaly skin due to impaired skin barrier and keratinization, often caused by variants in filaggrin-related pathways. Symptoms usually begin in childhood and can vary in severity with climate and age. Many cases improve with moisturization and keratolytic skin care.
Zydus Lifesciences received USFDA final approval for 32 mg bosentan tablets for pediatric PAH and Ammonium Lactate Cream, 12%, while launching an affordable respiratory device in India.
Zydus Lifesciences Limited received final FDA approval for Ammonium Lactate Cream, 12%, a generic of Lac-Hydrin Cream. The topical prescription medication treats xerosis and ichthyosis vulgaris, with annual U.S. sales of $15 million.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04750161 |
The Role Of Neutrophil Proteases As Global Regulators Of Il-1 Family Cytokine Activity In Skin Disorders |
UNKNOWN | |
| NCT03173547 |
A Six Week Topical Cream Study for Subjects With Ichthyosis Vulgaris |
COMPLETED | PHASE2 |
| NCT02978209 |
Comparison of Different Concentrations of Carbamide as Moisturizers in Ichthyosis Vulgaris |
UNKNOWN | NA |
| NCT01016106 |
Genetic Screening for Filaggrin Mutation in Atopic Dermatitis and Ichthyosis Vulgaris in the African American Population |
COMPLETED | NA |
